{"brief_title": "An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects", "brief_summary": "To characterize the pharmacokinetics of orally administered FLT (in a liquid formulation) after single doses in both the fed and fasting states; to assess the effect of food on the oral bioavailability of FLT", "condition": ["HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["Alovudine"], "criteria": "Inclusion Criteria Patients must have: - Positive ELISA test confirmed by Western blot analysis. - Asymptomatic. - Willing to sign an informed consent. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Oral candida infection documented by morphology or by a response to antifungal therapy within two months prior to study entry. - Oral hairy leukoplakia at any time prior to entry. - Temperature > 37.8 C. - Any malignancy other than cutaneous basal cell carcinoma or cervical carcinoma in situ. - Significant chronic underlying medical illness which would prevent continuous participation in this clinical trial. - Unwilling to sign an informed consent. - Zidovudine induced hematological toxicity. Prior Medication: Excluded: - Therapy with antiretroviral drugs or immunomodulators within seven days before entry. - Therapy with any investigational drug during the preceding 30 days. Patients may not have: - Oral candida infection documented by morphology or by a response to antifungal therapy within two months prior to study entry. - Oral hairy leukoplakia at any time prior to entry. - Temperature > 37.8 C. - Any malignancy other than cutaneous basal cell carcinoma or cervical carcinoma in situ. - Significant chronic underlying medical illness which would prevent continuous participation in this clinical trial. - Unwilling to sign an informed consent. - Zidovudine induced hematological toxicity.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Food", "mesh_term": ["HIV Infections", "Immunologic Deficiency Syndromes", "Acquired Immunodeficiency Syndrome", "Alovudine", "Dideoxynucleosides"], "id": "NCT00002260"}